These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34821080)

  • 1. The prognostic value of heart rate at discharge in acute decompensation of heart failure with reduced ejection fraction.
    Bahouth F; Elias A; Ghersin I; Khoury E; Bar O; Sholy H; Khoury J; Azzam ZS
    ESC Heart Fail; 2022 Feb; 9(1):585-594. PubMed ID: 34821080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insufficient reduction in heart rate during hospitalization despite beta-blocker treatment in acute decompensated heart failure: insights from the ASCEND-HF trial.
    Kitai T; Grodin JL; Mentz RJ; Hernandez AF; Butler J; Metra M; McMurray JJ; Armstrong PW; Starling RC; O'Connor CM; Swedberg K; Tang WH
    Eur J Heart Fail; 2017 Feb; 19(2):241-249. PubMed ID: 27634557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resting heart rate in ambulatory heart failure with reduced ejection fraction treated with beta-blockers.
    Varian KD; Ji X; Grodin JL; Verbrugge FH; Milinovich A; Kattan MW; Tang WHW
    ESC Heart Fail; 2020 Oct; 7(5):3049-3058. PubMed ID: 32757485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-Blockers and 1-Year Postdischarge Mortality for Heart Failure and Reduced Ejection Fraction and Slow Discharge Heart Rate.
    Park JJ; Park HA; Cho HJ; Lee HY; Kim KH; Yoo BS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ
    J Am Heart Assoc; 2019 Feb; 8(4):e011121. PubMed ID: 30755071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of High-Dose Beta-Blockers in Patients with Heart Failure with Preserved Ejection Fraction and Elevated Heart Rate.
    Lam PH; Gupta N; Dooley DJ; Singh S; Deedwania P; Zile MR; Bhatt DL; Morgan CJ; Pitt B; Fonarow GC; Ahmed A
    Am J Med; 2018 Dec; 131(12):1473-1481. PubMed ID: 30076815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mortality benefit of carvedilol versus bisoprolol in patients with heart failure with reduced ejection fraction.
    Choi KH; Lee GY; Choi JO; Jeon ES; Lee HY; Lee SE; Kim JJ; Chae SC; Baek SH; Kang SM; Choi DJ; Yoo BS; Kim KH; Cho MC; Park HY; Oh BH
    Korean J Intern Med; 2019 Sep; 34(5):1030-1039. PubMed ID: 30317846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serial heart rate measurement and mortality after acute heart failure.
    Ancion A; Tridetti J; Nguyen Trung ML; Oury C; Lancellotti P
    ESC Heart Fail; 2020 Feb; 7(1):103-106. PubMed ID: 31800172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discharge heart rate and β-blocker dose in patients hospitalized with heart failure: Findings from the OPTIMIZE-HF registry.
    DeVore AD; Mi X; Mentz RJ; Fonarow GC; Van Dyke MK; Maya JF; Hardy NC; Hammill BG; Hernandez AF
    Am Heart J; 2016 Mar; 173():172-8. PubMed ID: 26920611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect on Mortality of Higher Versus Lower β-Blocker (Metoprolol Succinate or Carvedilol) Dose in Patients With Heart Failure.
    Ajam T; Ajam S; Devaraj S; Fudim M; Kamalesh M
    Am J Cardiol; 2018 Sep; 122(6):994-998. PubMed ID: 30049457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Significance of Resting Heart Rate and Use of β-Blockers in Atrial Fibrillation and Sinus Rhythm in Patients With Heart Failure and Reduced Ejection Fraction: Findings From the Swedish Heart Failure Registry.
    Li SJ; Sartipy U; Lund LH; Dahlström U; Adiels M; Petzold M; Fu M
    Circ Heart Fail; 2015 Sep; 8(5):871-9. PubMed ID: 26243796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of tolvaptan dose on cardiac mortality in patients with acute decompensated heart failure after hospital discharge.
    Matsumoto K; Ehara S; Nakamura Y; Otsuka K; Kawase Y
    Heart Vessels; 2018 Oct; 33(10):1204-1213. PubMed ID: 29687159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute decompensated heart failure in a North Indian community hospital: Demographics, clinical characteristics, comorbidities and adherence to therapy.
    Onteddu SH; Wangchuk G; Sharma AJ; Mohan JC
    Indian Heart J; 2020; 72(1):27-31. PubMed ID: 32423557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent Acute Decompensated Heart Failure Admissions for Patients With Reduced Versus Preserved Ejection Fraction (from the Atherosclerosis Risk in Communities Study).
    Caughey MC; Sueta CA; Stearns SC; Shah AM; Rosamond WD; Chang PP
    Am J Cardiol; 2018 Jul; 122(1):108-114. PubMed ID: 29703442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure.
    Fröhlich H; Torres L; Täger T; Schellberg D; Corletto A; Kazmi S; Goode K; Grundtvig M; Hole T; Katus HA; Cleland JGF; Atar D; Clark AL; Agewall S; Frankenstein L
    Clin Res Cardiol; 2017 Sep; 106(9):711-721. PubMed ID: 28434020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta blockers and chronic heart failure patients: prognostic impact of a dose targeted beta blocker therapy vs. heart rate targeted strategy.
    Corletto A; Fröhlich H; Täger T; Hochadel M; Zahn R; Kilkowski C; Winkler R; Senges J; Katus HA; Frankenstein L
    Clin Res Cardiol; 2018 Nov; 107(11):1040-1049. PubMed ID: 29774407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart rate, beta-blocker use, and outcomes of heart failure with reduced ejection fraction.
    Ibrahim NE; Gaggin HK; Turchin A; Patel HK; Song Y; Trebnick A; Doros G; Maya JF; Cannon CP; Januzzi JL
    Eur Heart J Cardiovasc Pharmacother; 2019 Jan; 5(1):3-11. PubMed ID: 29490032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different Impact of Changes in Left Ventricular Ejection Fraction Between Heart Failure Classifications in Patients With Acute Decompensated Heart Failure.
    Yamamoto M; Seo Y; Ishizu T; Nishi I; Hamada-Harimura Y; Machino-Ohtsuka T; Sato K; Sai S; Nakatsukasa T; Sugano A; Baba M; Obara K; Aonuma K; Ieda M
    Circ J; 2019 Feb; 83(3):584-594. PubMed ID: 30674752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NT-proBNP Response to Sacubitril/Valsartan in Hospitalized Heart Failure Patients With Reduced Ejection Fraction: TRANSITION Study.
    Pascual-Figal D; Wachter R; Senni M; Bao W; Noè A; Schwende H; Butylin D; Prescott MF;
    JACC Heart Fail; 2020 Oct; 8(10):822-833. PubMed ID: 32800508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors, Trends, and Outcomes (Among Older Patients ≥65 Years of Age) Associated With Beta-Blocker Use in Patients With Stable Angina Undergoing Elective Percutaneous Coronary Intervention: Insights From the NCDR Registry.
    Motivala AA; Parikh V; Roe M; Dai D; Abbott JD; Prasad A; Mukherjee D
    JACC Cardiovasc Interv; 2016 Aug; 9(16):1639-48. PubMed ID: 27539683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of the stress hyperglycemia ratio on mortality and rehospitalization rate in patients with acute decompensated heart failure and diabetes.
    Zhou Q; Yang J; Wang W; Shao C; Hua X; Tang YD
    Cardiovasc Diabetol; 2023 Jul; 22(1):189. PubMed ID: 37495967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.